Contura Orthopaedics Ltd
Congress Stand 51
Category: Joint implants, Injectable Mechano-Modulating Synovial Implant
https://hcp.arthrosamid.com
020 7421 7400
[email protected]
Contura Orthopaedics, part of the Contura Group, delivers innovative, non-surgical solutions for knee osteoarthritis. Its flagship product, Arthrosamid®, is a non-biodegradable, injectable mechano-modulating synovial implant (2.5% iPAAG) for knee osteoarthritis. By restoring synovial elasticity and dampening mechanosensitive signalling associated with disease progression, it offers a surgery-free treatment option that bridges the gap between injectable therapies and joint replacement.
Developed and manufactured by Contura International, a global leader in hydrogel technology, Arthrosamid® offers a safe, effective alternative to surgery. With proven clinical outcomes and sustained symptom relief, Contura Orthopaedics is redefining osteoarthritis care—empowering orthopaedic surgeons with a transformative option for improving patient quality of life.
To find out more visit: https://hcp.arthrosamid.com.
Product
Product Name: Arthrosamid®
Product Type: Injectable Mechano-Modulating Synovial Implant
Product Summary / Description: Arthrosamid® is a non-biodegradable, injectable mechano-modulating synovial implant (2.5% iPAAG) for knee osteoarthritis.
Resources
Company Document
Promotional Video